Actionable news
0
All posts from Actionable news
Actionable news in ARIA: ARIAD Pharmaceuticals, Inc.,

Barbarian At The Gate: ARIAD Pharmaceuticals (ARIA)

The average volume for ARIAD Pharmaceuticals has been 4.2 million shares per day over the past 30 days. ARIAD has a market cap of $1.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.92 and a short float of 21.6% with 11.42 days to cover. Shares are up 12.8% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates ARIAD Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow and generally disappointing historical performance in the stock itself. Highlights from the ratings report include:

  • The company, on the basis of change in net income from the same quarter one year ago, has underperformed when compared to that of the S&P 500 and the Biotechnology industry average. The net income...

More